Chemoinformaics analysis of 1-Hydroxy-3,5,6,7-tetramethoxyxanthen-9-one
| Molecular Weight | 332.308 | nRot | 4 |
| Heavy Atom Molecular Weight | 316.18 | nRig | 17 |
| Exact Molecular Weight | 332.09 | nRing | 3 |
| Solubility: LogS | -3.569 | nHRing | 1 |
| Solubility: LogP | 2.788 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 16 |
| nHA | 7 | APOL | 44.6727 |
| nHD | 1 | BPOL | 25.5993 |
| QED | 0.735 |
| Synth | 2.373 |
| Natural Product Likeliness | 1.151 |
| NR-PPAR-gamma | 0.776 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.952 |
| Pgp-sub | 0.001 |
| HIA | 0.015 |
| CACO-2 | -4.751 |
| MDCK | 0.0000393 |
| BBB | 0.028 |
| PPB | 0.75879 |
| VDSS | 0.948 |
| FU | 0.28075 |
| CYP1A2-inh | 0.691 |
| CYP1A2-sub | 0.981 |
| CYP2c19-inh | 0.313 |
| CYP2c19-sub | 0.843 |
| CYP2c9-inh | 0.407 |
| CYP2c9-sub | 0.91 |
| CYP2d6-inh | 0.153 |
| CYP2d6-sub | 0.879 |
| CYP3a4-inh | 0.459 |
| CYP3a4-sub | 0.464 |
| CL | 5.608 |
| T12 | 0.576 |
| hERG | 0.026 |
| Ames | 0.522 |
| ROA | 0.451 |
| SkinSen | 0.618 |
| Carcinogencity | 0.032 |
| EI | 0.348 |
| Respiratory | 0.446 |
| NR-Aromatase | 0.854 |
| Antiviral | Yes |
| Prediction | 0.805083 |